Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
Dibo-Cohen
J M
JM
Department of Pharmacy, Hospital Cochin, Paris, France.
Conort
O
O
Conti
F
F
Bernard
D
D
Hazebroucq
G
G
Calmus
Y
Y
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D003365:Costs and Cost Analysis; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine